Post Conference Perspectives

Steven Nathan, MD, discusses how key findings from CHEST 2024, including survival predictors from the IPF-PRO Registry and the potential of inhaled treprostinil for CTD-PAH, are shaping new approaches to managing IPF and PAH, with a focus on early diagnosis, personalized treatments, and improving patient outcomes.

Javed Butler, MD, MPH, MBA, discusses The American Journal of Managed Care® Post Conference Perspectives from European Society of Cardiology Congress 2024 in London, United Kingdom, focusing on key updates in heart failure management, including the implications of the FINEARTS-HF trial findings on finerenone, the role of β-blockers and dapagliflozin, and the need to address unmet needs in treatment strategies for patients with mildly reduced and preserved ejection fractions.

A key opinion leader analyzes pivotal non-small cell lung cancer trials presented at ASCO 2024, including LAURA, CHRYSALIS-2, TROPION-Lung05, and CheckMate 9LA, discussing their implications for treatment strategies in non-small cell lung cancer.

Evan J. Lipson, MD, from Johns Hopkins University School of Medicine contributes key updates in melanoma treatment presented at ASCO 2024 in Chicago, Illinois.

Joseph Mikhael, MD, shares insights surrounding key updates in multiple myeloma management as presented at EHA 2024.

Alfred L. Garfall, MD, shares insights to recent data surrounding the multiple myeloma treatment landscape as presented at ASCO 2024 in Chicago, Illinois.

Richard Adler, MD, FACS, provides updates on Dry Eye Disease (DED) presented at the American Academy of Ophthalmology (AAO) 2023 conference.

Siamak Daneshmand, MD, explores genitourinary cancer updates presented at ESMO 2023.

Patrick Forde, MBBCh, offers crucial perspectives on breakthroughs in Non-Small Cell Lung Cancer from ESMO 2023.

A discussion surrounding highlights and updates from the 2023 World Stroke Congress.

John L. Marshall, M.D., discusses highlights of the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2023 and the latest advancements in colorectal cancer treatment.

Erin Michos, MD, MHS, provides a recap of the 2023 Annual Scientific Session and Expo at the World Congress of Cardiology.

An overview of the 2023 ASCO Gastrointestinal Cancers Symposium is presented by John L. Marshall, MD.

Guillermo Garcia-Manero, MD, provides insights surrounding myelodysplastic syndrome (MDS) from the ASH 2022 Annual Meeting and Exposition.

Carlos M. De Castro, MD, provides updates regarding treatment for paroxysmal nocturnal hemoglobinuria (PNH) from the ASH 2022 Annual Meeting and Exposition.

Arlene Siefker-Radtke, MD, shares key takeaways from her experience at ESMO 2022, focused on advanced or metastatic urothelial cancer.

Dr Millie Das, MD discusses updates from the 2022 World Conference on Lung Cancer regarding non-small cell lung cancer (NSCLC).

Expert insight on multiple myeloma management updates from the ASH 2021 annual meeting.

Robert Toto, MD, reviews key takeaways from the 2021 Academy of Managed Care Pharmacy meeting regarding healthcare resource utilization for patients with chronic kidney disease (CKD).

Petros Grivas, MD, PhD, reviews emerging data from the 2021 ASCO GU Virtual Symposium on the role of immune checkpoint inhibitors for the treatment of advanced and metastatic urothelial carcinoma.

An expert in the field of multiple myeloma discusses key data releases from ASH 2020.

An expert in the management of hypertrophic cardiomyopathy discusses the burden of disease, existing treatment options, unmet needs, and explores data from an emerging class of agents, myosin inhibitors.

Infectious disease expert discusses key data releases from ID Week 2020 within the field of HIV care.